CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
Baby JASPER +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01874327
NCT01874327N/ACompleted

Joint Engagement in Infants at Risk for ASD: Integrating Treatment With Biomarkers

University of California, Los Angeles·interventional·Posted Jun 11, 2013·Updated Oct 10, 2018

In Brief

A clinical study evaluating Baby JASPER and Standard Baby Classroom for Children at Risk for ASD. Completed, enrolled 110 participants across 1 site.

Detailed Summary

The study will evaluate the efficacy of a novel intervention implemented in a classroom setting aimed at improving joint attention and joint engagement skills with infants who are at risk of developing an Autism Spectrum Disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJun 11, 2013
Enrollment StartJan 1, 2013
Primary CompletionAug 1, 2018
Study CompletionSep 1, 2018
TodayJul 2, 2026
Enrollment to primary: 5.6 yearsPosted 13.1 years ago

Interventions

Baby JASPERbehavioral

Intervention focuses on core deficits of joint attention, play, engagement, and regulation embedded within AEPS curriculum

Standard Baby Classroombehavioral

Assessment, Education and Programming System (AEPS) for Infants and Children curriculum focused on early developmental milestones in fine and gross motor, cognitive, adaptive and social areas